Despite significant medical advancements in the oncology space, 30% of patients in the GSK/Harris Poll survey said they never ...

AstraZeneca’s earnings were boosted by its oncology, cardiovascular, respiratory and immunology (R&I), and rare disease ...

Set to become compulsory Nov. 20, the regulation isn't likely to make pharma ads easier for consumers to comprehend, but ...

By joining CG Life, Allison Davis is reconnecting with CEO David Ormesher and COO Jon Sawyer, who she previously worked with ...

Donald Hammen, 80, and his longtime next-door neighbor in south Minneapolis, Julie McMahon, have an understanding. Every ...

Havas Health named Anna Maria Marra as CEO of Europe on Tuesday morning, a role in which she will lead and oversee all ...

Nothing in Idaho law says an elected county coroner must follow any national standards for death investigations. So, many of ...

The firm’s Cultured research also found 75% of consumers still want companies to connect with culture, despite missteps in ...

The campaign’s approach was borne out of the fact that the target audience of 18- to 35-year-olds tunes out a lot of ...

Agency for Nature was originally created in response to research showing Britain ranks bottom for connection to nature in ...

Voters in three states — Arizona, Missouri, and Nevada — chose on Tuesday to advance protections for abortion rights in their ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...